# A Study of How the Body Breaks Down and Eliminates LY2623091

> **NCT02242981** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY2623091

## Key facts

- **NCT ID:** NCT02242981
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242981, "A Study of How the Body Breaks Down and Eliminates LY2623091". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02242981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*